)
Optiscan Imaging (OIL) investor relations material
Optiscan Imaging Status Update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Transformation and Commercialization Strategy
Transitioning from OEM to private label manufacturer, focusing on proprietary devices and software for direct market control.
Strategic partnerships with leading institutions like Mayo Clinic, Australian Clinical Labs, and Long Grove Pharmaceuticals support clinical data collection and regulatory submissions.
Internal upskilling, manufacturing expansion, and automation are underway to meet regulatory and commercialization goals.
Cash injections from R&D tax refunds and a successful AUD 17.75 million capital raise provide funding for clinical and regulatory activities.
Product and Clinical Development Milestones
Multiple clinical studies initiated, including GI imaging in Germany, breast cancer imaging in Australia, and a first-in-human head and neck cancer imaging study in Perth using InVueⓇ and InForm™ devices.
The head and neck cancer study will collect intra-operative imaging data, recruit 50 patients, and support US FDA submissions and AI algorithm advancement.
Veterinary device Inspector progressing toward a mid-2026 US launch, with FDA submission planned for early/mid 2026.
InView and InForm devices are leading regulatory submissions, with anticipated launches in 2027.
Telepathology and AI-based software tools are in advanced development, with clinical deployment expected in 2026.
Technology and Clinical Significance
InVueⓇ delivers high-resolution, sub-cellular imaging of soft tissue during surgery, enabling real-time diagnosis and treatment.
Devices provide detailed microscopic insights, aiding assessment and monitoring of cancer presence and surgical margin clearance.
Intravenous fluorescein sodium is used as a contrast agent, aligning with future US studies.
The study is non-interventional, gathering vital imaging data without disrupting standard care.
Optiscan’s technology enables live, non-destructive, 3D, in-vivo digital imaging at the single-cell level.
Next Optiscan Imaging earnings date
Next Optiscan Imaging earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage